May 10 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2024 Mar 31, 2023 Mar 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 43.51 78.14 48.90 20.20
(-44.3 pct) (+15.4 pct) (+12.4 pct) (+5.7 pct)
Operating 3.00 20.54 5.00 150 mln
(-85.4 pct) (-28.9 pct) (+66.5 pct) (-89.4 pct)
Recurring 3.41 20.68 5.20 250 mln
(-83.5 pct) (-27.3 pct) (+52.7 pct) (-84.4 pct)
Net
Net 1.48 16.01 3.40 100 mln
(-90.8 pct) (-19.3 pct) (+129.6 pct) (-90.8 pct)
EPS 12.30 yen 132.97 yen 28.24 yen 0.83 yen
Ann Div 17.00 yen 42.00 yen 17.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 17.00 yen 42.00 yen 17.00 yen
NOTE - Takara Bio Inc..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T